Cordoba Advisory Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cordoba Advisory Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+1,425	New	+$193K	0.05%	134
2026 Q1	–	Sell	-6,962	Closed	-$849K	–	156
2025 Q4	$849K	Buy	+6,962	New	+$798K	0.21%	79

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Cordoba Advisory Partners's XBI Position: Q2 2026 in Review

Cordoba Advisory Partners opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,425 shares worth $226K. The stake represents 0.05% of the portfolio and ranks #134 among its holdings. This is a return to the name: Cordoba Advisory Partners previously reported a position in XBI as recently as Q4 2025.

Cordoba Advisory Partners first reported a position in XBI in Q4 2025 and has held it in 2 quarters since. The position peaked at $849K in Q4 2025. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Cordoba Advisory Partners held 1,425 shares of State Street SPDR S&P Biotech ETF worth $226K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Cordoba Advisory Partners position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.05% of Cordoba Advisory Partners's portfolio in Q2 2026, its #134 holding.
Cordoba Advisory Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 2 quarters since.
Cordoba Advisory Partners's State Street SPDR S&P Biotech ETF position peaked at $849K in Q4 2025.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cordoba Advisory Partners's 13F filing for Q2 2026, filed 21 Jul 2026.